Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Varenzin Ca1 Patent Expiration

Varenzin Ca1 is a drug owned by ELANCO US INC. It is protected by 5 US drug patents filed from 2027 to 2031. All patents are active. Details of Varenzin Ca1’s patents and their expiration are given below.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Patent Number Drug Patent Expiry Status
Patent Data
US8389520 20 Dec, 2029 Active
US8987261 27 Nov, 2027 Active
US8653111 12 Oct, 2027 Active

About Varenzin Ca1

Varenzin Ca1 is a drug owned by ELANCO US INC. Varenzin Ca1 uses Molidustat as the active ingredient.

Active Ingredient:

Varenzin Ca1 uses Molidustat as the active ingredient. Check out other Drugs and Companies using Molidustat ingredient.